|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Bodisen Biotech (BBOI.OB) Completes Dual Listing Of Shares On London Stock Exchange AIM; Raised US$21.36 Million Strategic Financing With UK Institutional Investors
2/6/2006 11:19:12 AM
NEW YORK--(BUSINESS WIRE)--Feb. 6, 2006--Bodisen Biotech, Inc., (AMEX:BBC, London AIM:BODI, website: www.bodisen.com), the first China based environmentally friendly bio fertilizer company listed on a US stock exchange, announced the successful completion of financing and dual listing of its US shares on the London Stock Exchange AIM market. Bodisen sold 1,643,836 (slightly over 9% of post offering outstanding shares) at GBP 7.30 (Approximately US$13) per share. No warrants or options were associated with this offering. Bodisen has a total of 17,764,836 shares outstanding after the transaction. Bodisen will primarily use the proceeds to expand manufacturing facilities and marketing to two new large farming regions of China which each has the similar manufacturing capacity and revue potentials as Bodisen's existing facilities.
|
|
|
|
|
|
|
|
|
|
|